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Background: The number of resuscitated cardiac arrest patients suffering from anoxic-ischemic encephalopathy is
considerable. However, outcome prediction parameters such as somatosensory evoked potentials need revision
because they are based on data predating the implementation of mild therapeutical hypothermia and because data
from our own laboratory suggest that they may fail to predict prognosis accurately. The present research project
“Hypoxia and Outcome Prediction in Early-Stage Coma” is an ongoing observational prospective cohort study that
aims to improve outcome prediction in anoxic coma by limiting the effects of falsely pessimistic predictions at the
intensive care unit.
Methods: Our outcome analysis is based on functional and behavioural definitions. This implies the analysis of the
positive predictive value of prognostic markers yielding either positive or negative results. We also analyse the effect of
covariates adjusted for age and sex such as sociodemographic variables, prognostic variables and treatment factors on
functional and behavioural outcomes, with mixed effects regression models (i.e. fixed and random effects). We
expect to enrol 172 patients based on the result of previous research. The null hypothesis is that there is a
probability of <10 % that a positive outcome will be observed despite the presence of any of the predictors of a
poor/negative outcome. We test the null hypothesis against a one-sided alternative using a Simon’s two-stage
design to determine whether it is warranted to recruit the full number of patients suggested by a power analysis.
The second stage has a design with a Type I error rate of 0.05 and 80 % power if the true response rate is 25 %.
Discussion: We aim to make a significant contribution to the revision and improvement of current outcome
prediction methods in anoxic-ischemic encephalopathy patients. As a result, neurocritical care specialists worldwide will
have considerably more accurate methods for prognosticating the outcome of anoxic-ischemic encephalopathy following
cardiac arrest. This will facilitate the provision of treatment tailored to individual patients and the attainment of an optimal
quality of life. It will also inform the decision to withdraw treatment with a level of accuracy never seen before in the field.
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A rapidly aging population constantly presents chal-
lenges to society in general and the health care system
in particular. One such challenge is the increasing num-
ber of patients resuscitated after cardiac arrest (CA) who
suffer from anoxic-ischemic encephalopathy (AIE) due
to global cerebral anoxia [1]. There are approximately
80,000 such patients every year in Germany alone, which
gives the issue a very high epidemiological and economic
relevance [2, 3]. Faced with ethical concerns and the
problem of limited resources, specialists in neurocritical
care use a series of tests during the first two weeks after
admission to predict outcome in anoxic coma. These
tests are focused on the prediction of a poor outcome.
Current criteria define poor outcome as either death or
unconsciousness after 1 month, or unconsciousness or
severe disability after 6 months. According to these cri-
teria, poor outcome could be accurately predicted by the
following factors: “the presence of myoclonus status epi-
lepticus on day 1, the bilateral absence of the N20 wave
of somatosensory evoked potentials (SSEPs) or a blood
concentration of neuron specific enolase (NSE) above
33 mcg/L at days 1–3, and absent pupillary and corneal
reflexes or a motor response no better than extension
(M1 -2) at day 3” [4, 5]. However, it can be argued that
these parameters need to be revised because they are
based on data that predate the widespread implementa-
tion of mild therapeutical hypothermia after cardiopul-
monary resuscitation (CPR) and because data from our
own laboratory suggest that they fail to predict progno-
sis accurately in a considerable number of patients. In a
previous study, we examined over a six-year period the
rehabilitation outcome of a cohort of 113 adult patients
with AIE following cardiac arrest [4]. These patients
had chronic disorders of consciousness at the time of
admission for inpatient neurorehabilitation. We found
that 25 % of patients, who recovered consciousness and
the ability to communicate during inpatient rehabilitation,
had presented no sign of cortical SSEP responses during
the initial phase at the intensive care unit (ICU). In other
words, they were patients who fulfilled the current criteria
for certain death or unresponsive wakefulness syndrome
[5]. In fact, a regression model revealed that a malignant
SSEP did not seem to be an independent predictor of
rehabilitation outcome (i.e. functional or behavioural
outcome) [4].
A systematic review and recent meta-analysis of the
relevant literature on the state-of-the-art on early pre-
dictors (≤7 days) of poor neurological outcome in adult
patients, who received therapeutic hypothermia after
cardiac arrest and survived, found that “a bilaterally ab-
sent N20 SSEP wave anytime, a nonreactive EEG after
re-warming or a combination of absent ocular reflexes
and M ≤ 2 after re-warming“could be used to predict apoor outcome with 0 % false positive rates (100 % speci-
ficity; upper limit of 95 % CI <10 %) within a period
equal to or shorter than 7 days after cardiac arrest [6].
However, the same review and meta-analysis reported
that only in 11 % of the studies treating teams were
blinded from the results of the predictor being investi-
gated. Since life-sustaining therapy is withdrawn from
most patients with SSEP indicating bilateral loss of cor-
tical potentials, it is difficult to know whether the result-
ing death of the patient is due to the natural course of
the condition itself or to the fact that life-sustaining
therapy was withdrawn too early [7]. This suggests that
a self-fulfilling prophecy (i.e. falsely pessimistic predic-
tions) could be biasing results and that current outcome
prediction could be considerably less accurate than it is
believed to be.
The present study “Hypoxia and Outcome Prediction
in Early-Stage Coma” (HOPE) responds precisely to the
need to improve current outcome prediction in anoxic
coma by limiting the effects of the above-mentioned
self-fulfilling prophecy. The primary objective of HOPE
is to examine the accuracy of currently accepted param-
eters in the prediction of an outcome in AIE in general
and the specificity of SSEP in particular.
HOPE does not use a narrow definition of outcome
based entirely on outcome measures that focus on fac-
tors such as the extent of physical ability or functional
independence in activities of daily life (ADL) [8]. We
have observed that regaining consciousness and commu-
nication skills, despite functional dependence, is some-
times considered a favourable outcome by a previously
comatose patient and his/her family [4]. Our own clin-
ical experience is confirmed by a report on the subject-
ive quality of life (QOL) of locked-in syndrome (LIS)
patients with extreme motor impairment [9]. This study
found that the experience of a good subjective QOL in a
significant number of LIS patients was not dependent on
the absence of extreme motor impairment and that de-
pression was not dependent on its presence. In fact, the
ability to communicate with others rather than the ex-
tent of physical ability was found to be crucial for a good
subjective QOL in such patients.
Methods
Study design
HOPE is an ongoing 2.5-year multi-centre observational
prospective cohort study with seven study visits and data
entry points (t0-t6) and a follow-up period of 12 months.
The primary endpoints are completion of the follow-up
period or patient death.
The main characteristics of HOPE are:
 Control for self-fulfilling prophecy in the outcome
prediction process in the ICU
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and neurorehabilitation phases
 Use of the Coma Recovery Scale - Revised Version,
a sensitive measure of level of consciousness
 In-depth and systematic examination of the
predictive value of SSEP, EEG and NSE
Participants
We expect to enrol 172 patients who remain comatose
after CPR.
Inclusion criteria
 Age: 18–75 years
 Cause of admission to ICU: Cardiac arrest
 GCS <9 at time of study enrolment (3 to 8 days after
cardiac arrest). This includes GCS scores obtained
during a temporary cessation of analgosedation of at
least 30 minutes as long as only short-lasting drugs
such as propofol or sufentanil were used
 Informed consent signed by legal guardian/next-of-kin
If a legal guardian has not yet been appointed by
court, the closest relative is asked for consent. As soon
as a legal guardian has been appointed, he or she is
asked to renew consent.
Exclusion criteria
 Stroke (as it may interfere with SSEP testing)
 Pre-existing chronic disorder of consciousness
 Terminal malignant disease, as it increases the
likelihood of not being alive for the 12-month
follow-up
 Highly unlikely survival until the end of the
12-month follow-up due to conditions such as
multi-organ failure based on the judgment of a
critical care physician
 Existing advanced directive that demands the
cessation of therapy/life support
 Withdrawal of life-support/palliative care during
treatment in the ICU
 Use of barbiturates for sedation
 Inability to determine GCS <9 (see inclusion
criteria) due to prolonged deep analgosedation
Recruitment sources
We established a study consortium consisting of five
major tertiary care hospitals with cardiology ICUs and
neurology departments as well as four neurorehabilitation
centres in the south of the German state of Bavaria
receiving patients from these ICUs.
During the acute phase, we screen CA patients
admitted to cardiology ICUs. Neurological prognostictesting is assigned to the neurology department of the
same hospital. We transfer patients to a neurorehabilitation
centre part of HOPE once the decision for neurorehabilita-
tion is made and the legal representatives of the patients
agree. It must be noted that patients or their legal guard-
ians are allowed to select a non-participating rehabilitation
centre. When that is the case or neurorehabilitation is not
advised, study visits planned for the rehabilitation phase
(i.e. t3-t5) are not carried out. However, we conduct as
planned a 12-month follow-up at the place of residence of
the patient regardless of whether the patient received study
visits after being discharged from the ICU or not.
Measures
In addition to collecting clinical and demographic data in
accordance with Utstein-style recommendations, we assess
the current level of consciousness, relevant neuropsycho-
logical functions, health-related quality of life (HRQOL) as
well as information on functional outcome and activities
of daily living (ADL) [10]. Table 1 details the complete
assessment catalogue with its respective instruments.
The most crucial part of our study is determining the
current level of consciousness. We used for that purpose
the revised version of the Coma Recovery Scale (CRS-R)
[11]. The CRS-R allows a precise categorisation of the
current level of consciousness based on a structured and
systematic clinical examination of auditory, visual, motor,
oromotor, communication, and arousal functions.
Data collection
Study centres collect data prospectively following the data
acquisition timeline in Table 2. Visits t0 to t2 take place at
ICUs; visits t3 to t5 at the neurorehabilitation centres; and
visit t6 at the location of residence of the patient
12 months after day 0.
Biostatistical concept and statistical analysis
Determining whether an outcome is truly poor requires
making a distinction between functional and behavioural
outcome as well as input from caregivers on what the
patient would have wanted. We ask family members or
significant others at the time of patient enrolment at the
ICU what the patient would have considered a favourable
outcome. In other words, given the possibility of a per-
manent unresponsive wakefulness syndrome, would the
patient have considered either a functional outcome such
as being able to lead an independent life or a behavioural
outcome such as regaining functional communication
skills the only acceptable favourable outcome.
Therefore, we use in our analysis functional and behav-
ioural definitions of favourable outcome. In practical terms
this implies the analysis of the positive predictive value
of dichotomous prognostic markers (e.g. a favourable or
unfavourable SSEP).
Table 1 Assessment categories and instruments
Assessment category Instruments
Sociodemographic factors Age, gender, marital status, highest educational degree
Comorbidity Modified Cumulative Illness Rating Scale (mCIRS) [20, 21].
Severity of illness Simplified Acute Physiology Score (SAPS II) [22, 23].
Prognostication tests EEG, median-nerve somatosensory evoked potentials (SEP), NSE
Activities of daily living (ADL) Outcome Barthel index and the Barthel index for Early Rehabilitation (BI) [23–26].
• Level of consciousness Coma recovery scale -revised (CRS-R) [11], Glasgow Coma Scale (GCS) [27], Full outline of
unresponsiveness (FOUR) [28]
• Health status Neurological post-acute Core Set of the International Classification of Functioning,
Disability and Health (ICF) [29]
• Cognitive functioning Since the most commonly observed cognitive impairments in patients with an anoxic-ischemic
brain injury are disturbances of attention/processing speed, memory, and executive function
we use the subtests of the Cologne Neuropsychological Screening for Stroke Patients (German:
Koelner Neuropsychologisches Screening für Schlaganfall-Patienten) for these functions [30, 31].
• Psychosocial Outcome German version of the Hospital Anxiety and Depression Scale (HADS-D) [32–34].
• Quality of life Short Form 36 (SF-36) Questionnaire (for patients as well as for closest care-providing relative) [35]
• Life Satisfaction (LS) and satisfaction
with decision making at the ICU
The LS of the patient and the closest care-providing person is measured by the “Question
on Life Satisfaction (German: Fragen zur Lebenszufriedenheit-Module; FLZ-M) [36], and
satisfaction with decision making at the ICU is measured with questions such as
“in retrospective, I would have decided exactly the same on the ICU” using a 5-point scale.
• Overall outcome The modified Rankin scale (mRS) [37, 38], and the Cerebral Performance Category [39, 40]
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predicated upon the capacity to lead an independent
daily life (i.e. functional outcome), we use both a
Barthel-Index score and a Modified Rankin Scale
(mRS) score to quantify and categorise a favourable
functional outcome. However, in the case of a
favourable outcome defined in terms of the extent of
the recovery of consciousness (i.e. behavioural out-
come), we analyse CRS-R scores to quantify it. It must
be noted that the recovery of full consciousness asTable 2 Data acquisition timeline and type of data to be acquired d
Timeline
t0: t1: t2: t3:
Screening Days 3–8 Days 8–14 Adm
Location of data collection ICU ICU ICU Reh
Assessment categories
• Inclusion/Exclusion criteria ✓
• Sociodemographic factors ✓
• Comorbidity ✓
• Severity of illness ✓
• Prognostication tests ✓ ✓ ✓
• Level of consciousness ✓ ✓ ✓
• Activities daily living ✓ ✓
• Further patient outcomemeasured by the CRS-R implies the regaining of func-
tional communication skills.
We also analyse the effect of covariates adjusted for
age and sex such as sociodemographic variables, prog-
nostic variables and treatment factors (e.g. use of thera-
peutic hypothermia) on functional (i.e. Barthel-Index
scores) and behavioural (i.e. CRS-R scores) outcomes
with mixed effects regression models (i.e. fixed and ran-
dom effects). This method of analysing longitudinal data
has been reported to be highly effective to examineuring study visits/time points
t4: t5: t6:
ission Rehab Rehab week 4 Discharge Rehab Follow-Up 1 year
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of data [12, 13].
Power analysis and sample size
Clinicians typically consider that the likelihood of a
poor outcome is high when they observe the following
factors (i.e. negative predictors) during ICU treatment
with a specificity > 90 % and a confidence interval of
95 %: (i) bilateral loss of cortical N20 median nerve
SEP potentials, (ii) loss of at least one brainstem reflex,
(iii) non-reactive EEG, (iv) or a NSE above 75 mcg/L
during ICU treatment [1, 3, 6, 14, 15]. Based on this
fact, our null hypothesis is that there is a probability of
<10 % that a favourable outcome will be observed
despite the presence of any of the predictors of a poor/
negative outcome. We should reiterate that the term
“favourable outcome” in this particular context refers
to the outcome most likely preferred by the patient in
the opinion of his or her closest relative or significant
other.
We test the null hypothesis against a one-sided alter-
native using a Simon’s two-stage design to determine
whether it is warranted to recruit the full number of
patients suggested by the result of the power analysis
we performed [16]. In the first stage as soon as we
manage to recruit 42 % (i.e. the first 72 patients) of the
total number of patients needed (i.e. 172) we will
analyse the data of this subset to determine whether
the null hypothesis can be rejected. In practical terms
this means that if <10 % of patients in this early subset
present a positive outcome despite negative predictors,
the study must be aborted because the null hypothesis
could not be rejected. However, if we observe that
>10 % do present a favourable outcome despite nega-
tive predictors, we would proceed to the second stage
of the study, namely, the recruitment of the full num-
ber of patients necessary to achieve sufficient statistical
power (i.e. 172). In this second stage we adopt a design
that yields a Type I error rate of 0.05 and 80 % power if
the true response rate is 25 %.
The null hypothesis will be rejected if 28 or more
favourable outcomes are observed in these 172
patients. That is, if 25 % or more patients do present a
positive outcome despite a negative predictor. This
calculation is based on the assumption that 25 % of
enrolled patients have at least one negative predictor.
This is a conservative assumption if we consider
previous studies from our own research group [4, 11].
Control for sampling bias and self-fulfilling prophecy
Sampling bias
In order to avoid sampling bias, we screen consecu-
tively CA patients admitted to one of the participat-
ing intensive care units (ICU) based on the inclusionand exclusion criteria of the study. Screening logs are
filled out for all CA patients admitted to these ICUs
and include specific reasons for excluding a given
patient.
Bias due to self-fulfilling prophecy
As explained above, life-sustaining therapy is withdrawn
from most patients with bilateral loss of cortical SSEP
responses. It is consequently difficult to know whether
the resulting death of the patient is due to the natural
course of the condition or to the fact that life-sustaining
therapy was withdrawn too early [7]. Therefore, most
cardiac arrest outcome studies can be considered heavily
biased due to a self-fulfilling prophecy.
To control for this bias we implement the following
measures:
a) All ICU team members involved in counselling of
relatives and strategic decision-making are made
aware of the existing conflicting data on prognostic
test accuracy.
b) Study information material and informed consent
forms contain information on the likelihood of
recovery of consciousness and functional
independence depending on the presence of negative
predictors.
c) Study personnel from the study coordination centre
are available to ICUs in the study for additional
counselling and realistic expectation management of
relatives and family decision makers.
d) As part of the battery of case report forms (CRF),
we provide a standardised prognostication form for
ICU physicians containing a multimodal procedure
based on the recommendations in the literature [17].
Its purpose is to lend perspective to prognostic test
results such as brain stem reflexes, EEG, SSEP, and
NSE so that they can convey as accurately as
possible to patients’ surrogates the degree of
prognostic uncertainty and the likelihood of a given
outcome. Physicians are prompted to select one of
the semi-quantitative conclusions shown in Fig. 1.
e) Patients are excluded from the study if life-sustaining
therapy is withdrawn or if pre-existing advance
directives call for palliative care.
It must be noted that ICU clinical decision makers are
asked to follow their best ethical judgment at all times
and are therefore free to follow treatment strategies that
do not adhere to the study protocol.
Bias due to quality control issues
Study staff receives assessment training and retraining
regularly. The study coordination centre supervises as-
sessments and provides a manual and a data dictionary
Fig. 1 Proposed multimodal prognostic approach to avoid falsely pessimistic outcome predictions
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turn check data before submission for completeness,
plausibility, accuracy, consistency and outliers.
Ethical considerations
As HOPE is a non-interventional trial its examinations
are part of the clinical standard operating procedures at
participating centres and comply with the guidelines of
the German Neurological Society (Deutsche Gesellschaft
für Neurologie; DGN) for AIE. HOPE was approved by
the ethics committee of the University of Munich and is
funded by the Else Kroene-Fresenius Foundation, a non-
profit-organisation that supports medical and humani-
tarian projects through a peer-review process.
HOPE endeavours to ensure that patients do not experi-
ence death due to withdrawal of care. However, medical
strategy regarding continued versus palliative care or
withdrawal of care is solely dependent on the decision
of patient surrogates and senior ICU physicians and not
on study protocol.
Study limitations
Since HOPE is an observational study, there is no inter-
vention and medical decision-making is at the sole dis-
cretion of attending physicians. The latter fact has a
direct impact on the implementation of the recom-
mended course of action to control for the effect of a
self-fulfilling prophecy during the outcome prediction
process at the ICU. Physicians are free to accept or ig-
nore project directives in that regard. However, ignoring
project recommendations to avoid a self-fulfilling proph-
ecy renders the data of the patient in question unusable
for the purposes of the project. As this may slow down
data collection, we seek to heighten the engagement of
physicians at project sites by offering training work-
shops, a frequent newsletter, briefings by the leading
investigator and the project manager as well as updates
on the condition of patients even after they leave the
ICU. This is undertaken while emphasizing at all times
that the objectives of the project must not influence
medical strategy.Another possible limitation of HOPE is that it may be
affected by the “ICU variable”, namely regional differ-
ences in healthcare provision (e.g. infrastructure and or-
ganisation specific to Germany) [18]. However, since the
outcome prediction parameters being examined by the
study are part of routine basic examinations at ICUs
around the world, it is safe to assume that the ICU vari-
able is not likely to limit the generalisation of results.
Discussion
To our best knowledge, HOPE is the first observational
multicentre prospective cohort study on coma prognosis
to control for the effect of a possible self-fulfilling
prophecy at the ICU and to cover the acute and neuror-
ehabiltation phases with a long-term follow-up longer
than the usual three or six months. Follow-up accuracy
is ensured by the fact that, unlike most previous studies,
we employ the CRS-R, a behavioural scale more sensi-
tive than the Glasgow Coma Scale. We strongly believe
that we will be able to make a significant contribution
to the revision and improvement of current outcome
prediction methods in anoxic-ischemic encephalopathy
(AIE) patients. As a result, neurocritical care specialists
worldwide will have considerably more accurate
methods for prognosticating the outcome of AIE follow-
ing cardiac arrest. This will facilitate the provision of
treatment tailored to individual patients and the attain-
ment of an optimal QOL. It will also inform the decision
to withdraw treatment with a level of accuracy never
seen before in the field.
In a Time Magazine article, which offered the general
public a rare accurate look into cutting-edge research on
disorders of consciousness, we find a poignant question.
After referring to patient cases that illustrate the difficulty
of predicting an outcome, the author asks candidly: “…
patients labelled vegetative typically stay that way—but
sometimes they don’t. So where’s the line between res-
ignation and hope?” [19]. We believe that HOPE will
make a significant contribution to bringing us consid-
erably closer to finding the answer to this important
question.
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